Cargando…

A tumor-associated autoantibody panel for the detection of non-small cell lung cancer

Lung cancer is the second most frequent malignancy and the leading cause of cancer-associated death worldwide. Compared with patients diagnosed at advanced disease stages, early detection of lung cancer significantly improved the 5-year survival rate from 3.3% to 48.8%, which highlights the importan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Ruijun, Zhao, Feng, Zhou, Haiying, Wang, Zengsong, Lin, Dang, Huang, Lu, Xie, Wenling, Chen, Jiawen, Zhou, Lamei, Zhang, Ni, Huang, Chaoyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757608/ https://www.ncbi.nlm.nih.gov/pubmed/36531074 http://dx.doi.org/10.3389/fonc.2022.1056572

Ejemplares similares

Diagnostic value of tumor-associated autoantibodies panel in combination with traditional tumor markers for lung cancer
por: Xu, Yu, et al.
Publicado: (2023)

Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features
por: Xu, Leidi, et al.
Publicado: (2022)

The combination of a seven-autoantibody panel with computed tomography scanning can enhance the diagnostic efficiency of non-small cell lung cancer
por: He, Tianyu, et al.
Publicado: (2022)

Case study of an autoantibody panel for early detection of lung cancer and ground-glass nodules
por: Huo, Yunli, et al.
Publicado: (2020)

Identification and Validation of Novel Serum Autoantibody Biomarkers for Early Detection of Colorectal Cancer and Advanced Adenoma
por: Wang, Hejing, et al.
Publicado: (2020)

Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant Diagnosis
por: Wang, Weidong, et al.
Publicado: (2020)

Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer
por: Zhou, Juan, et al.
Publicado: (2021)

Development of a salivary autoantibody biomarker panel for diagnosis of oral cavity squamous cell carcinoma
por: Hsueh, Pei-Chun, et al.
Publicado: (2022)

The presence of autoantibodies is associated with improved overall survival in lung cancer patients
por: Jing, Keying, et al.
Publicado: (2023)

Early detection of lung cancer in a real-world cohort via tumor-associated immune autoantibody and imaging combination
por: Liu, Zhong, et al.
Publicado: (2023)

Identification of novel serum autoantibody biomarkers for early esophageal squamous cell carcinoma and high-grade intraepithelial neoplasia detection
por: Chen, Zhibin, et al.
Publicado: (2023)

Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer
por: Fang, Qiyu, et al.
Publicado: (2023)

A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer
por: Hong, Chao-Qun, et al.
Publicado: (2021)

A Diagnostic Panel of DNA Methylation Biomarkers for Lung Adenocarcinoma
por: Shen, Nan, et al.
Publicado: (2019)

Discovering Panel of Autoantibodies for Early Detection of Lung Cancer Based on Focused Protein Array
por: Jiang, Di, et al.
Publicado: (2021)

Tumor regression rate, PD-L1 expression, pembrolizumab/nab-paclitaxel–based regimens, squamous cell carcinoma, and comorbidities were independently associated with efficacy of neoadjuvant chemoimmunotherapy in non-small cell lung cancer
por: Hu, Xingsheng, et al.
Publicado: (2023)

Blood Tumor Mutational Burden as a Predictive Biomarker in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
por: Ma, Yuhui, et al.
Publicado: (2021)

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer
por: Hanssen, Annkathrin, et al.
Publicado: (2015)

Identification of novel tumor-associated antigens and evaluation of a panel of autoantibodies in detecting oral cancer
por: Xie, Weihong, et al.
Publicado: (2023)

Resection of Early-Stage Second Primary Non-small Cell Lung Cancer After Small Cell Lung Cancer: A Population-Based Study
por: Zhang, Rusi, et al.
Publicado: (2020)

Panel of autoantibodies against multiple tumor‐associated antigens for detecting gastric cancer
por: Hoshino, Isamu, et al.
Publicado: (2017)

Association of MUC19 Mutation With Clinical Benefits of Anti-PD-1 Inhibitors in Non-small Cell Lung Cancer
por: Zhou, Li, et al.
Publicado: (2021)

Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) From Small Volume Specimens for Precision Oncology: Molecular Subtyping of Non-Small Cell Lung Cancer From Fine Needle Aspirates
por: Su, Jing, et al.
Publicado: (2021)

Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer
por: Knapp, Brendan, et al.
Publicado: (2022)

Evaluation of the Lung Immune Prognostic Index in Non-Small Cell Lung Cancer Patients Treated With Systemic Therapy: A Retrospective Study and Meta-Analysis
por: Huang, Litang, et al.
Publicado: (2021)

Local therapy treatment conditions for oligometastatic non-small cell lung cancer
por: Zhang, Suli, et al.
Publicado: (2022)

Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers
por: Rom, William N, et al.
Publicado: (2010)

Efficacy of autoantibodies combined with tumor markers in the detection of lung cancer
por: Mu, Yinyu, et al.
Publicado: (2022)

Diagnostic Accuracy of Next Generation Sequencing Panel using Circulating Tumor DNA in Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Sebastião, Mariana M., et al.
Publicado: (2020)

Identification of Novel Autoantibodies Based on the Human Proteomic Chips and Evaluation of Their Performance in the Detection of Gastric Cancer
por: Cui, Chi, et al.
Publicado: (2021)

Gene Panel of Persister Cells as a Prognostic Indicator for Tumor Repopulation After Radiation
por: Zhao, Yucui, et al.
Publicado: (2020)

Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization
por: Zhang, Jianying, et al.
Publicado: (2022)

Detection of Circulating Tumor Cell Molecular Subtype in Pulmonary Vein Predicting Prognosis of Stage I–III Non-small Cell Lung Cancer Patients
por: Dong, Jingsi, et al.
Publicado: (2019)

Relationship Between Thyroid Autoantibodies and Recurrence of Papillary Thyroid Carcinoma in Children and Adolescents
por: Huang, Dongmei, et al.
Publicado: (2022)

Unique Profile of Driver Gene Mutations in Patients With Non-Small-Cell Lung Cancer in Qujing City, Yunnan Province, Southwest China
por: Zhou, Yongchun, et al.
Publicado: (2021)

Circulating tumor DNA detection in MRD assessment and diagnosis and treatment of non-small cell lung cancer
por: Fang, Xiaoxu, et al.
Publicado: (2022)

An updated network meta-analysis of EGFR-TKIs and combination therapy in the first-line treatment of advanced EGFR mutation positive non-small cell lung cancer
por: Qi, Yuexiao, et al.
Publicado: (2022)

Identification of Prognostic Model Based on Immune-Related LncRNAs in Stage I-III Non-Small Cell Lung Cancer
por: Li, Qiaxuan, et al.
Publicado: (2021)

Application Value Analysis of Seven-Autoantibody Panel in the Lung Cancer Screening in Yunnan
por: Li, Wenrun, et al.
Publicado: (2022)

Survival analysis of patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment of Yunnan in southwestern China: a real-world study
por: Lin, Yanping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9fmsqes74bkj98e18tgs72tje0